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B.W. body weight 
CBA corticosterone binding activity 
OFFT dried fat free tissue weight 
E estradiol benzoate 
EPpn ovariectomized virgin rats treated with E and P 
per da> for 20 days 
F hydrocortisone acetate 
FSH follicle stimulating hormone 
GH growth hormone 
HLS ovariectomized, hypophysectomized virgin rats 
treated with E and P for 10 days followed by 
E, P, GH, PRL and F for 10 days and finally 
GH, PRL and F for an additional 3 days 
(simulated lactation) 
ML? ovariectomized, partially hypophysectomized 
virgin rats treated with E and P for 10 days 
followed by E, P, GH, PRL and F for 10 days 
and finally GH, PRL and F for an additional 
3 days 
HPS ovariectomized, hypophysectomized virgin rats 
treated with E and P for 10 days followed by E, 
P, GH, PRL and F for 10 days (simulated pregnancy) 
HPU ovariectomized, sham-hypophysectomized virgin 
rats treated with E and P for 10 days followed 
by E, P, GH, PRL and F for 10 days 
k clearance constant (.693/T^) 
LT,L2,Lg days 1, 3 and 5 of lactation 
X mammary gland:blood partition coefficient 
LH luteinizing hormone 
iv 
o.v. ovarian venous blood 
P progesterone 
Pgi day 21 of pregnancy 
PG prostaglandin 
PRL prolaction 
p.v. peripheral venous blood 
RCG rat chorionic gonadotropin 
T, clearance rate 
T. thyroxin 
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INTRODUCTION 
During pregnancy, mammary gland development may be divided into 
two phases: mammogenesis and lactogenesis. The proliferation of the 
lobulo-alveolar system which occurs gradually throughout pregnancy is 
defined as mammogenesis. The increase in cell number near term and 
the differentiation of these cells into competent secretory daughter 
cells is defined as lactogenesis. After parturition, lactation 
commences and the maintenance of this milk secretion is designated 
galactopoiesis. 
Since the 1920's and 1930's many experiments have been performed 
to attempt to simulate the lobulo-alveolar growth that occurs during 
pregnancy and then to induce milk secretion in these developed glands 
to better understand the hormonal mechanisms of mammary gland 
ur u I I I CI au I uii aiiu une iiiiuiauiun ui iauuauiuii« 
In classical experiments, Chen et al. (15) and Lyons et al. (81) 
demonstrated that ovariectomized, hypophysectomized, adrenalectomized 
rats given estrogen, progesterone, growth hormone, prolactin and 
hydrocortisone developed mammary glands similar to late pregnancy. 
They induced lactation in these same animals by removing estrogen-
progesterone but continued stimulation with growth hormone, prolactin 
and hydrocortisone. The extent of lobulo-alveolar proliferation and 
lactational performance was evaluated by histological examination of 
whole mount tissues. 
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With the advent of a more quantitative measure of growth, DNA 
and RNA analysis. Moon et al. (94) and Griffith and Turner (46) 
observed that 1 yg estrogen and 3 mg progesterone was sufficient for 
the hormonal replacement of the ovary while Anderson and Turner (4) 
demonstrated that 250 yg hydrocortisone was adequate for adrenal gland 
substitution. The hormonal balance of the anterior pituitary, however, 
was more difficult to establish. Griffith and Turner (46) observed 
that 1-2 mg growth hormone and prolactin, along with estrogen-
progesterone, stimulated maximal mammary gland growth in ovariectomized 
rats. But, their results are complicated by the fact that the anterior 
pituitary was present. Cole and Hopkins (19), using ovariectomized, 
hypophysectomized rats, asserted that estrogen, progesterone, growth 
hormone (40 yg) and prolactin (2 mg) developed mammary glands equivalent 
to late pregnancy and that the removal of estrogen-progesterone along 
with continued administration of growth hormone, prolactin plus 
hydrocortisone stimulated lactation. However, in analyzing their DNA 
and RNA data, the number of cells and the synthetic capability, in the 
ovariectomized, hypophysectomized simulated mammary glands were lower 
than ûl'Hi/Minh thou mav hauo inHiiroH milk co/'vo+inn 
in these mammary glands, the DNA and RNA values were indicative of 
late pregnancy rather than early lactation. 
I repeated these experiments by injecting estrogen, progesterone, 
growth hormone, prolactin and hydrocortisone to stimulate full lobulo-
alveolar development in ovariectomized, hypophysectomized Sprague-Dawley 
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rats. Milk secretion was induced by estrogen-progesterone withdrawal 
but continued treatment with growth hormone, prolactin and hydro­
cortisone. Suspecting that the five hormone complex might not be 
sufficient to stimulate full mammary gland growth, mammary gland blood 
flow as well as DNA and RNA was measured to determine whether this could 
be a limiting factor in mammary gland proliferation. 
The xenon clearance method was selected to measure blood flow 
through the mammary gland because it permitted the injection of a tracer 
directly into the mammary gland thus avoiding the difficulty of 
isolating a single mammary gland blood vessel. Blood flow was calculated 
by measuring the xenon clearance rate and mammary gland:blood partition 
coefficient for each experimental group. 
Because this research problem considers both the hormonal control 
of mammary gland proliferation and the importance of blood flow in 
this growth, the literature review is organized into two major sections. 
The first section concerns the development and proliferation of the 
mammary gland while the second section deals with mammary gland blood 
vessels and methods of measuring mammary gland blood flow. 
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LITERATURE REVIEW 
Stages of Mammary Gland Development 
The first recognizable structure concerned with the development of 
the mammary gland is a raised band of ectoderm which appears on either 
side of the midline of the embryo, the mammary band. Along this band 
appears a narrower ridge of ectoderm, the milk line or milk crest. 
The mammary band gradually disappears, the milk line diminishes in 
length and becomes fragmented into a series of thickenings or nodules 
of ectodermal cells. These nodules sink into the dermis and become 
mammary buds, the primordia of the future mammary glands. Each bud 
elongates, the base remains attached to the epidermis while the distal 
end penetrates into the mesenchyme so that a cord-like structure is 
formed, the primary mammary cord. The primary cord gives rise to two 
or three secondary buds which in turn elongate and branch. These 
branched cords develop a lumen and become ducts. In this manner, the 
duct system of the mammary gland is laid down before birth (107). 
Most of the increase in mammary gland growth from birth to puberty 
is due to an increase in connective tissue and deposition of fat in 
the mammary gland; however, a certain amount of parenchymal growth does 
take place. After birth and until day 22, the rat mammary gland 
increases in area at the same rate as body surface area, isometric 
growth. At approximately 23 days of age, the time of weaning, the 
mammae come under the influence of ovarian hormones and the phase of 
isomstry changes to one of positive allometry, the specific growth 
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rate of the glands becoming three times that of the body surface. This 
rapid growth period precedes puberty by 13-19 days (21). 
In species with short estrous cycles, as in the rat, mammary gland 
growth is limited to an extension and branching of the duct system. 
A striking feature of these growing glands is the presence of club-
shaped terminal end buds around their periphery. Small cyclic changes 
do occur in the proliferation wf the duct system during the estrous 
cycle with a more active phase of duct growth in early estrus followed 
by regression towards diestrus. 
During pregnancy the majority of mammary gland epithelial pro­
liferation occurs. Further extension and branching of the duct system 
occurs, alveoli develop and the lobulo-alveolar system progressively 
takes over most of the space occupied by the stroma, so that the gland 
becomes a compact mass of lobules with alveoli separated from each 
other by septa of connective tissue. 
In the nursing female rat, shortly after the litter is weaned, 
there is a decrease in the amount of epithelial tissue, sn increase in 
the stromal adipose tissue, accumulation of fat and protein droplets 
in the epithelial cells, and vacuolization of the cells. The reduction 
in epithelial tissue is caused by a decrease in cellular volume and 
localized degeneration of cells without rupture of the duct system. 
The myoepithelial cells do not undergo degeneration but play an 
important role in bridging the gap where necrotic cells have been 
eliminated to hold the surviving cells together. The stored secretory 
material is digested without the participation of lysosomes. However, 
lysosomes play an active role in decreasing the cellular volume of 
5 
surviving cells and in the degeneration of the dying cells. The 
necrotic cells become vacuolated and are either eliminated as colostrum 
bodies into the alveolar lumina or lysed and eliminated in the 
interstitial tissue. By the fifth day of involution, nuclei, mito­
chondria, fat droplets and other structures are released into the 
alveoli and ducts. By the fifteenth day of involution, only small 
ducts with intact cells remain (115). 
Hormones of Pregnancy and Lactation 
To simulate mammary gland development of pregnancy and lactation 
in ovariectomized, hypophysectomized animals using exogenous hormones, 
one must first understand the hormonal fluctuations during normal 
pregnancy and lactation. The hormonal changes during pregnancy and 
lactation, more specifically, parturition and lactogenesis, have stimulated 
much research over the past few decades, i have attempted to summarize 
these hormonal changes in the pregnant and lactating rat. 
Hormones of pregnancy (Fig. 1) 
During the first few days of pregnancy there are transitory 
fluctuations in many of the hormones involved in gestation. There is 
a steady fall in serum gonadotropins during the initial days of 
pregnancy although a significant increase in LH release is detected on 
day 3. This temporary rise in LH induces an estrogen surge later on 
day 4 approximately 24 hours prior to the time of ovo-implantation 
(148). This estrogen (E) rise prepares the uterus for implantation and 
may prime the luteal cells for the action of pituitary prolactin (PRL) 
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Fig. 1. Concentration of hormones in the rat during pregnancy 
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(119, 145). Following these first few days of pregnancy until day 19, 
estrogen secretion remains low. 
Progesterone is needed throughout pregnancy to maintain the 
functional integrity of the endometrium. The corpora lutea of pregnancy 
are the major source of progesterone in the rat. The regulation of 
corpus luteum function was extensively studied by Matthies (82, 83) 
and Rothchild and colleagues (93, 103, 112). It is well documented 
that removing the pituitary luteotrophic factors by hypophysectomy 
of rats before day 12 of pregnancy, terminates pregnancy. If, however, 
hypophysectomy is performed on or after day 12, the corpora lutea are 
maintained, progesterone secretion remains high and pregnancy proceeds 
to term (7, 18 , 36 , 82 , 83). Matthies (82 , 83) demonstrated that there 
is some trophoblastic component of the 12-day conceptus synthesizing a 
protein hormone which is released into the maternal circulation. This 
hormone, rat chorionic gonadotropin (RCG), is capable of acting on 
the corpora lutea to induce progesterone secretion. Therefore, it 
seems that maternal anterior pituitary prolactin is essential for 
corpora lutea maintenance and progesterone secretion during the first 
half of pregnancy while "placental prolactin" (RCG) is responsible 
for corpora lutea maintenance during the second half of pregnancy. In 
later studies, Rothchild and colleagues (95, 103, 112) examined more 
closely the luteotrophic factors responsible for corpus luteum 
maintenance during the first half of pregnancy by injecting prolactin 
and LH inhibitors on different days of gestation. They concluded that 
during the first 12 days of pregnancy, luteal progesterone secretion 
is maintained by two intricately timed controlling mechanisms: 
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pituitary prolactin from days 1 through 7, and a placental luteotrophin 
(RCG)-LH complex from days 8 through 12. Between the evening of day 7 
and morning of day 8, RCG assumes the role of prolactin in assuring 
luteal progesterone secretion. RCG apparently requires the synergistic 
presence of LH to accomplish this end, but only until day 12. After 
day 12, RCG alone maintains the corpora lutea. 
These conclusions by Matthies and Rothchild are supported by an 
examination of the changes in prolactin, RCG, LH and progesterone 
concentrations that occur during pregnancy. 
Serum prolactin values are highly erratic during the first half 
of pregnancy but stabilize thereafter at very low levels until day 21. 
The large day-to-day fluctuation in prolactin may be explained by a 
semicircadian release of prolactin with peaks occurring late in the 
light and dark periods (13). These fluctuations are detected only 
during the first ten days of gestation (95; 96). Estrogen inhibits 
the release of prolactin inhibiting factor from the hypothalamus thereby 
allowing the release of prolactin from the anterior pituitary (1). 
Because estrogen release is elevated in the initial days of gestation 
this may explain the higher serum prolactin concentration during the 
first few days of pregnancy. The low level of serum prolactin during 
most of pregnancy has been attributed to the high amounts of pro­
gesterone present which may partially or completely block the prolactin 
stimulating action of estrogen (85). There is also the possibility 
that serum prolactin concentration is low because estrogen secretion 
is also low (145). 
At about the time pituitary prolactin becomes dispensible for 
corpus luteum maintenance, serum prolactin has declined and rat 
chorionic gonadotropin (RCG) is detectable. It was recently observed 
that RCG is present in small amounts as early as day 5 of pregnancy 
and reaches its peak concentration by day 12 when it becomes the major 
luteotrophin (121). Shortly after RCG reaches its peak, there is an 
increase in progesterone release indicating that the primary action of 
RCG must be to enhance progesterone secretion. 
Besides luteotrophic action, RCG also has luteolytic properties 
(36, 83). Several types of corpora lutea are present during the first 
half of pregnancy while only one type persists through the second half 
of gestation. Matthies (83) suggested that the declining release of 
maternal pituitary prolactin during mid-pregnancy causes some corpora 
lutea to become refractory to the stimulatory effects of luteotrophin. 
Therefore, wher. RCG reaches its peak at aid-pregnancy, it destroys 
all luteal tissue that has become refractory and enhances the secretory 
activity of the remaining corpora lutea. 
Although Linkie and Niswender (74) were unable to detect any 
discrete changes in LH release between days 5 and 12 of gestation, 
Morishige et al. (96) found a conspicuous fall in serum LH between days 
11 and 13, precisely the time when the pituitary becomes dispensable 
to the maintenance of pregnancy in the rat (7, 83). After the first 
few days of pregnancy, serum FSH is present in only basal concentration. 
The same explanation for the basal release of prolactin during most 
of gestation may also apply to the release of serum gonadotropins: 
either the large amount of progesterone present inhibits the 
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stimulatory effects of estrogen or the low level of estrogen is 
insufficient to stimulate the release of gonadotropins. 
Corticosterone binding activity (CBA) remains high and constant 
throughout pregnancy while the serum concentration of free cortico­
steroids remains low and constant until the last few days of gestation 
(37). 
During the last few days of pregnancy, there is a dramatic change 
in serum hormone concentrations. Progesterone secretion declines 
markedly beginning on day 19. The endocrine factors responsible for 
this drop in progesterone are not known. Because the fall in 
progesterone occurs before the rise in prostaglandins (PG) or LH, the 
luteolytic properties of these factors are not responsible for the 
decline in corpora luteal activity. It is possible that the decline 
in progesterone secretion may not be due to a luteolytic factor but 
rather to the withdrawal of luteotrophic support, i.e., a disruption of 
placental function thereby causing a drop in RCG release (67). 
The serum concentration of estrogen increases significantly a 
few days after the drop in progesterone. Coincidentally, prosta­
glandin concentration in the venous blood also increases. The function 
of the increase in estrogen secretion at the end of pregnancy may have 
a triple purpose: to stimulate the synthesis of PG by the uterus, to 
sensitize the uterus to the oxytocic properties of PG, and finally to 
trigger the LH release from the pituitary necessary for post-partum 
estrus and ovulation (67). 
Although corticosteroid binding activity remains constant until 
parturition, the amount of free serum corticosterone increases during 
the last few days of pregnancy. The fetal adrenal gland during the 
last two days of gestation secretes as much corticosteroid as do adrenal 
glands of mature animals. Corticotrophic activity of the fetal 
pituitary reaches a maximum between day 15 and 20. Corticosterone from 
the fetus can cross the placen+a by day 18 and may explain the increase 
in free corticosteroids at the end of pregnancy (37, 38). 
Hormones of lactation (Fig. 2) 
The decline in placental function at the end of pregnancy is 
associated with a decrease in RC6 and a reduction in corpora luteal 
function. The increase in prolactin release resulting from this fall 
in progesterone accompanied by an increase in estrogen secretion, 
causes luteolysis of these now refractory corpora lutea (82, 83). 
The shift in the estrogen-progesterone ratio resulting in estrogen 
dominance also stimulates the release of LH from the pituitary (1). 
This temporary rise in LH induces post-partum estrus and ovulation. 
New corpora lutea, with a fresh supply of progesterone, form after 
muulafinn anrl arp main+aineH hv thp lutem+rnnhir nrmnerfv nf nrmlarfin 
(82, 83). 
Follicular quiescence and maintenance of corpora lutea during 
lactation are attributed to the ability of the suckling stimulus to 
suppress the secretion of gonadotropins from the pituitary on the one 
hand, and to induce the secretion of prolactin on the other (31). 
Amenomori et al. (1) observed that prolactin release is directly 
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Fig. 2. Concentration of hormones in the rat during lactation 
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proportional to the number of suckling pups. Also, the characteristic 
features in the secretory pattern of progesterone during lactation 
reflect the pattern of prolactin release from the pituitary (146). 
A high serum prolactin concentration is maintained for at least 8 days 
but by the 15th day post-partum, serum prolactin values decrease 
significantly. This decline is probably due to the less intense 
suckling stimulus because the pups are beginning to eat solid food 
found in the cage (1). Paralleling the release of prolactin, 
progesterone values remain high until approximately day 10 of lactation, 
then gradually decline to basal concentrations by about day 16 
(131, 146). 
There is a precipitous decline in CBA activity early in lactation 
paralleled by an increase in free serum corticosteroid concentration. 
The suckling stimulus may also be involved in maintaining this higher 
release of corticosteroid during lactation (37). 
Hormonal mechanisms controlling parturition 
In a recent review, Wagner et al. (143) proposed a hypothetical 
model for the hormonal control of parturition in farm animals. This 
model may also be applicable to the rat. 
1. A stimulus to the fetal hypothalamus causes the fetal 
pituitary-adrenal axis to increase glucocorticoid secretion. This may 
result from the maturation of the appropriate hypothalamic centers 
making them responsive to stimuli that are already present (18, 60). 
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2. Increased prostaglandin production by the uterus follows the 
rise in fetal glucocorticoid production. The prostaglandins, through 
their oxytocic effect, increase myometrial activity in the uterus (67). 
3. With the decline in placental function comes the decrease in 
RCG and a reduction in corpora luteal function culminating in a decrease 
in maternal serum progesterone (82, 83). 
4. An increase in estrogen release occurs in late pregnancy. 
This is accompanied by increased prostaglandin production by the uterus 
(67). The shift in the estrogen-progesterone ratio resulting in 
estrogen dominance prepares the uterus for a stronger and more rhythmic 
response to the process of fetal expulsion. This altered ratio also 
increases the release of oxytocin from the posterior pituitary in 
response to neural stimuli from the reproductive tract and is important 
in the general relaxation of the birth canal and dilatation of the 
cervix and vagina. 
5. Finally with the aid of the rhythmic contractions of the 
myometrium, the fetus is expelled from the uterus. 
Because the rise in fetal adrenal corticosteroids precedes all the 
other hormonal changes in the maternal plasma just prior to parturition; 
it is postulated that the fetus is the trigger for parturition. 
Hormonal mechanisms of lactogenesis 
Theories for the hormonal inhibition of lactation during pregnancy 
and the initiation of lactation at parturition are presented by Meites and 
Turner (87), Fol ley (34) and Meites (85). The ovarian steroids play an 
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important role at different stages of pregnancy. The estrogen-pro­
gesterone equilibrium during most of pregnancy makes the mammary gland 
resistant to the stimulatory effects of lactogenic hormones. This 
estrogen-progesterone ratio inhibits the secretion of prolactin by the 
pituitary (85) and also probably the other constituents of the lactogenic 
hormone complex (34). At parturition the fall in plasma progesterone 
together with a temporary rise in estrogen secretion makes the mammary 
gland receptive to the pituitary hormones as well as stimulating their 
release. 
One of the constituents of the lactogenic hormone complex may be 
lacking during pregnancy. Nandi and Bern (99) and Gala and Westphal 
(37, 38) have suggested that adrenal corticosteroids constitute the 
limiting factor in the initiation of milk secretion during pregnancy. 
Nandi and Bern (99) and Talwalker et al. (129) demonstrated that the 
administration of exogenous glucocorticoid, but not prolactin or growth 
hormone, induces premature milk secretion in pregnant mice. They 
observed that the amount of prolactin and growth hormone required for 
good lobulo-alveolar development and lactogenesis were the same. 
Therefore, they concluded that an increase in prolactin secretion at 
parturition is not necessary or sufficient for the initiation of 
lactation. 
Free corticosteroid (biologically active) is in equilibrium with 
the fraction bound to plasma albumin and corticosteroid binding 
globulin (CBG). It is possible that the amount of biologically active 
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glucocorticoid present in the circulation during pregnancy is not 
sufficient to permit milk secretion. Pregnancy in the rat does not 
alter the total binding capacity or amount of CBG in the plasma (37); 
however, values for albumin-corticosteroid binding are significantly 
lower at the end of pregnancy resulting in an increase in free cortico­
steroid from the twentieth day of pregnancy (38), corresponding to the 
first signs of milk secretion. Because the administration of estrogens 
has been reported to potentiate the biological effects of corticoids 
(100), the increase in estrogen late in pregnancy may act in conjunction 
with the elevated free corticosteroid concentration to bring about the 
initiation of lactation. 
An important consideration overlooked by Nandi and Bern (99) and 
Gala and Westphal (37, 38), however, is that the placenta, more 
specifically RCG, causes a general body resistance to the biochemical 
effects of glucocorticoids (24). Therefore, it is most likely that 
the decline of placental function at the end of pregnancy along with 
the shift in the estrogen-progesterone ratio increases the sensitivity 
of the mammary gland to glucocorticoids and prolactin. The altered 
estrogen-progesterone ratio along with increasing amounts of free 
glucocorticoids and prolactin all synergize to cause lactogenesis. 
Although hormonal changes in the fetus may be considered the 
trigger for parturition, the fetal contribution to the circulating 
levels of maternal glucocorticoids is not essential for lactogenesis but 
sustained maternal adrenal activity is essential (8). 
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Simulation of Mammary Gland Development and Lactogenesis 
In vivo model for mammogenesis and lactogenesis 
The development of the mammary gland and initiation and continuation 
of lactation are under the control of several hormones as discussed 
previously. In the intact animal, the injection of any one hormone will 
usually result in a change in other hormonal concentrations. What is 
needed then is a model system in which the control of all pertinent 
concentrations of hormones is in the hands of the experimenter so that 
he can vary them one at a time. An ovariectomized, hypophysectomized 
or ovariectomized, hypophysectomized, adrenalectomized (triply operated) 
animal may serve as such a model. 
The validity of these artificially developed glands as models 
depends upon the faithfulness with which they represent the normally 
develcped manmary gland. Their suitability as models was initially 
judged qualitatively by their morphological characteristics, i.e., 
histological examination of whole mount tissues (81, 99). 
Quantitative methods also were developed to study the experimentally 
induced changes in mammary gland structure and function, i.e., DNA 
and RNA analysis (63). 
The use of DNA content as an index of cell number followed from 
the suggestion that the amount of DNA per somatic cell nucleus of a 
given species is constant (90, 140). This was later confirmed for the 
rat mammary gland during pregnancy and lactation (70, 133, 134). 
Kirkham and Turner (63) were the first to investigate the changes in 
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DNA content of the mammary gland during the lactational cycle. 
Subsequently, DNA values have been determined in the rat mammae at 
different stages of development. The results of some studies are 
summarized in Fig. 3. 
From such results Griffith and Turner (44) concluded that 21% 
of the total mammary growth occurs during the first ten days of 
pregnancy, and 50% after twenty days. Following parturition, there is 
a wave of cell division (40) and a corresponding increase in DNA. 
By day 5 of lactation, growth of the mammary gland is 98% complete (44). 
The major criticism against the use of DNA as an index of mammary 
gland proliferation has been that the mammary gland epithelial cells 
are surrounded by connective tissue and a fat pad. Is the increase in 
DNA of the mammary gland throughout pregnancy and early lactation 
indicative of an increase in the number of epithelial cells, an increase 
in the number of nuclei per cell, or an increase in the amount of 
connective and adipose tissue surrounding these parenchymal cells? 
Harkness and Harkness (51) reported little increase in collagen content 
of the mammary gland during the different stages of mammary gland 
development. Nicoll and Tucker (101) removed the mammary gland rudiment 
from one side of three week old mice. Some of these animals were mated 
while others remained nulliparous. They found that the virgin, gland-
free fat pads and those of the lactators were the same, indicating that 
the population of the adipose stroma did not increase. The question of 
polyploidy in mammary epithelial cells was dismissed by Persson (104). 
Thus, the increase in matisnary gland DNA during pregnancy and lactation 
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Fig. 3. DNA on a per 100 g body weight basis throughout pregnancy 
and lactation 
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represents a proliferation of epithelial cells. 
RNA as an index of protein synthesis was substantiated by 
quantitative biochemical studies (10, 25). The amount of RNA and the 
value of the RNA/DNA ratio (the amount of RNA per cell) have been 
used widely to indicate the protein synthetic capability of a tissue. 
Figure 4 summarizes the results of some of these studies. 
On the basis of such results, Greenbaum and Slater (40) divided 
mammary gland protein synthesis into two phases: that associated with 
the growth of the mammary gland during pregnancy, and that occurring 
after parturition for the maintenance of the mammary gland and the 
elaboration of milk proteins during lactation. 
In vivo studies 
Research efforts in mammary gland development during the 1920's 
and 1930's centered around three themes: first; that estrogen 
(estradiol benzoate, E) stimulated ductal growth; second, that 
progesterone (P), assuming estrogen priming, was responsible for 
lobulo-alveolar development; and third, that in order for estrogen and 
progesterone to have an effect on the mammary gland, a hormone(s) from 
the anterior pituitary was required (137, 138). 
With the advent of DNA analysis, a quantitative technique, these 
presumptions were confirmed. Moon et al. (94), using ovariectomized 
rats, found that the daily administration of 1 yg E for 19 days 
stimulated some mammary gland growth while the injection of 1 yg E + 
3 mg P for 19 days resulted in mammary gland development comparable 
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to that of 18 to 20 day pregnant animals. Increasing the amount of 
progesterone to 10 mg daily had little, if any, further beneficial 
effect on the growth of the mammary gland. Keeping the estrogen-
progesterone ratio the same but doubling the amount of each hormone 
was also of no advantage (46). Hypophysectomized rats, given the same 
hormonal treatment, manifested a regression in mammary gland development 
indicating that the anterior pituitary is necessary for estrogen-
progesterone stimulation of lobulo-alveolar growth (47). 
There is a great deal of contradictory evidence concerning the 
role of thyroxine (T^) and growth hormone (6H) in mammary gland 
development. Moon and Turner (93) injected 1 yg E + 3 mg P with 3 or 
6 yg T^ into ovariectomized rats for 19 days. The mean mammary gland 
DNA was similar to that of the estrogen-progesterone controls. However, 
when the concentrations of E and P were doubled, leaving the concen­
tration of T^ the same, the DNA was significantly increased. But, when 
this experiment was repeated, the higher levels of E and P had no 
additional benefit over the lower concentrations (66). 
Following an examination of mammary gland development and 
pituitary prolactin (PRL) content in ovariectomized rats treated with 
E, P and T^ with (0.0-2.0 yg) and without GH, Moon (91) observed a 
definite increase in mammary gland growth with the addition of GH, 
although there was no significant difference between the different 
concentrations of GH used. Moon concluded that GH stimulated mammary 
gland growth by enhancing the release of prolactin and that these two 
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hormones in conjunction with E and P brought about lobulo-alveolar 
development. After performing pituitary autotransplants in rats. 
Mettes and Kragt (86) concluded that the role of may be to enhance 
the release of GH which, in turn, stimulates the release of PRL, 
thereby causing maintenance of body growth and indirectly the development 
of the mammary gland. 
Kumaresan and Turner (65) compared the effects of and GH in 
estrogen-progesterone primed, ovariectomized rats to that of normal 
pregnant animals. Their results, expressed as a percent increase 
of DNA/lOOg B.W. above the appropriate control group, are summarized 
below. 
Pregnant Ovariectomized, 
Treatment day 20 EP-jg 
GH N.S. N.S. 
T^ 26%+ 21%+ 
GH+T^ 29%+ 28%+ 
Although T^ induced mammary gland development in the ovariectomized 
rats, it had the same effect in the normal pregnant animals. This 
agrees with earlier results of Griffith and Turner (45). Therefore, 
if there is a synergism between E, P and T^ in stimulating mammary 
gland growth, it may not be of physiological importance. In contrast to 
Moon's (91) results, the GH treatment, both separately and in combination 
with T^, had no significant effect on mammary gland growth. However, 
GH did have an effect on somatic growth, either alone or in conjunction 
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with T^, as indicated by an increase in body weight. Therefore, the 
importance of and GH may be to maintain normal body growth and 
function, and only indirectly affect mammary gland development. 
Anderson and Turner (4) took the investigation of the hormone 
requirements for mammary gland development one step further by 
ovariectomizing and adrenalectomizing rats. Along with estrogen-
progesterone replacement, they found that between 100-250 yg hydro­
cortisone acetate (F) was optimum for mammary gland development. They 
considered glucocorticoids necessary, but not adequate for mammary gland 
development, since glucocorticoids alone did not stimulate growth. 
The interpretation of the results from the preceding experiments 
is complicated by the presence of the anterior pituitary. The anterior 
pituitary hormones play an important part in the development of the 
marmary gland and any exogenous administration of a hormone is likely 
to alter the pituitary release of other hormones which may enhance or 
mask the effects of the original treatment. Many investigators have 
continued to experiment with mammary gland simulation of pregnancy 
and lactation by using hypophysectomized rats. 
In his earlier work, Lyons et al. (80) demonstrated that 
ovariectomized, hypophysectomized rats given E, P and PRL consistently 
lost weight. Despite this weight loss, the treatment caused proliferation 
of mammary gland alveoli in the form of small lobules. By injecting 
GH as well as E, P and PRL, the usual weight loss was prevented and 
enhanced lobulo-alveolar growth occurred. Daily injections of E, P and 
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GH in the absence of PRL failed to cause lobulo-alveolar growth. This 
lends further support to the idea that the role of GH is to maintain 
body growth and function and only indirectly affects mammary growth. 
Lyons induced lactation in these same animals by removing E and P 
stimulation but continued with the administration of GH and PRL 
accompanied by ACTH. In a later study using triply operated rats, 
Lyons et al. (81) were able to induce milk secretion in competent 
mammary glands with PRL and glucocorticoids in the absence of GH again 
coming to the conclusion that GH was necessary for maintenance of body 
growth and only indirectly for mammary gland function. 
A similar experiment was carried out on triply operated plus 
thyroidectomized rats to determine the influence of thyroxine on the 
mammary gland (15). Again, it was concluded that thyroxine is not 
essential for mammary gland growth or lactation. 
All the above experimental results measured the extent of lobulo-
alveolar development and lactational performance on the basis of 
histological examination of whole mount mammary glands. Cole and 
Hopkins (19) repeated Lyons' earlier experiments on ovariectomized, 
hypophysectomized rats but evaluated lobulo-alveolar development and 
lactation by DNA and RNA analysis as well as histological examination. 
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Their results are summarized below. 
DNA 
mg/lOOg tissue 
189 + 69 
RNA 
mg/lOOg tissue 
110 + 73 
HPS 135 + 45 91 + 54 
HLS 198 + 59 105 + 58 
They concluded that the hormonal therapy of E, P, GH and PRL stimulated 
mammary gland growth equivalent to a normal 15 to 17 day pregnant rat, 
while continued treatment with GH, PRL and F produced lobulo-alveolar 
development of late pregnancy and stimulated milk secretion. However, 
they did not stimulate full lobulo-alveolar development of pregnancy 
in their simulated pregnant (HPS) group as is claimed by Lyons. 
Furthermore, although the DNA value for simulated lactation (HLS) is 
greater than HPS, indicating the wave of cell division associated with 
the onset of lactation, it is not significantly greater than the DNA 
of a normal animal in late pregnancy. Also, the synthetic capability 
(RNA) of the mammary glands of the HLS group simulates late pregnancy 
rather than early lactation. 
In vitro studies 
To better understand the hormonal requirements for lobulo-alveolar 
development, Ichinose and Nandi (56) cultured mammary gland tissue from 
a mouse that was pretreated with estrogen and progesterone. The 
incubation medium contained varied combinations of estrogen, progesterone, 
growth hormone, prolactin, aldosterone, and insulin. All media 
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containing insulin promoted epithelial maintenance, whereas media 
deficient in insulin, irrespective of the other hormones present, 
failed to do so. Media containing insulin but lacking either, or both, 
steroid and anterior pituitary hormones did not stimulate lobulo-
alveolar development. But, when all six hormones were included in the 
medium, epithelial proliferation took place during the first few days 
of incubation followed by the organization of these cells into lobules. 
The lobulo-alveolar inducing activity of the medium containing the full 
complement of hormones confirms in vivo results that both steroid and 
anterior pituitary hormones are necessary for full lobulo-alveolar 
formation. Furthermore, the in vitro results imply that the synergism 
between these hormones must lie at the target tissue. 
A more definitive explanation of the hormonal control of the 
initiation of milk secretion is possible from the results of mouse 
mammary gland organ cultures and studies of casein and lactose synthesis. 
Lockwood et al. (79) and Stockdale and Topper (125) monitored casein 
synthesis while Turkington and Hill (135) and Turkington et al. (136) 
measured lactose synthetase activity in mid-pregnant mammary gland 
expiants cultured iri media containing various combinations of insulin, 
hydrocortisone, and prolactin. 
After 96 hours of incubation in insulin and hydrocortisone, mouse 
mammary gland cells do not produce casein unless prolactin is added. 
If mitosis is prevented by the addition of colchicine, prolactin no 
longer stimulates casein synthesis. Therefore, cell division is 
essential before functional differentiation is possible. From these and 
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similar results a sequence of events was proposed: insulin is involved 
in the initiation of DNA synthesis and is required for mitosis; 
prolactin causes cell differentiation after mitosis if hydrocortisone 
is present sometime after DNA synthesis but before mitosis occurs 
(79, 126). 
Lactose synthetase, the enzyme concerned with lactose synthesis, 
is composed of two proteins: a galactosyl transferase and a-lactalbumin. 
During the latter half of pregnancy, galactosyl transferase activity of 
mouse mammary glands rises to nearly maximum values; however, a-lact­
albumin values remain low and rise to a maximum after parturition. 
Prolactin induces the synthesis of both these proteins in culture; 
progesterone prevents the increase in activity of a-lactalbumin but 
does not prevent the induction of galactosyltransferase activity. 
Progesterone injections into mice one or two days before parturition 
prevents the marked rise in a-lactalbumin concentration after 
parturition seen in non-injected controls (135, 136). These results 
further substantiate the importance of the high levels of progesterone 
during pregnancy in inhibiting the initiation of lactation. 
In surïïr.ary, a possible scheme for the initiation of lactation is 
presented in Fig. 5. 
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Mammary Gland Blood Vessels 
Major arteries of rat mammary glands 
The rat has six pairs of mammary glands: three thoracic, one 
abdominal and two inguinal. All of these glands receive their blood 
supply from the superficial blood vessels of the thoraco-abdominal 
wall (Fig. 6). 
The thoracic glands are supplied by superficial blood vessels 
from two main arteries, the internal and external mammary arteries. 
These arteries arise from the subclavian artery and run downward along 
the thoracic wall. The internal mammary artery, which terminates as 
the superior epigastric artery, furnishes several small branches which 
pass between the ribs to the skin. The external mammary artery mostly 
supplies the larger muscles in the thoracic area. 
The abdominal-inguinal mammary glands are usually supplied by 
vessels from the pudic-epigastric trunk which, in turn, arises from the 
common iliac artery. The pudic-epigastric trunk divides into many 
branches: inferior epigastric, superior and inferior external pudendal 
arteries and some branches that terminate directly in the mammary fat 
pad. The external pudendal artery also sends branches into the mammary 
fat pad. The superior epigastric artery springs from the femoral 
artery halfway down the thigh. It ends in a terminal anastomatic 
branch which perforates the abdominal wall and eventually anastomoses 
with the inferior epigastric artery, each sending small branches into 
the mammary gland. 
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If the pudic-epigastric trunk is missing, then the inferior 
epigastric and inferior external pudendal arteries arise from the 
hypogastric trunk, while the superior external pudendal arises from 
the external iliac artery (41 , 77, 137). 
Manmary gland capillaries during mammary gland development 
The distribution of blood vessels in the mammary gland is the same 
as those of the mammary fat pad. As the gland grows during pregnancy, 
the capillaries in the adipose tissue are assimilated by the developing 
ducts and alveoli as they are formed (77). In the early days of 
pregnancy, the capillary nets are restricted to the ductal regions. 
With advancing pregnancy and the formation of lobules and alveoli, 
the vascularity of the gland increases. The prominent capillary plexuses 
are now found in the region of the lobules and are no longer associated 
with the major ducts. Further increase in the r.ui^isr of lobule-
associated plexuses is observed until the fifteenth day of pregnancy. 
Beyond that time, and during lactation, the capillaries increase 
progressively in size but no new plexuses are formed. During post-
lactational involution, there is a decrease in vascularity and the 
capillary nets are no longer seen around the lobules but have regressed 
to the major ducts (124). 
The changes observed in the vascularity of the gland during 
pregnancy and lactation indicate that the capillary nets are found 
only in the proliferating (ductal system during early pregnancy) or 
actively sercreting areas (lobulo-alveolar system during late pregnancy 
34 
and early lactation). The increase in the number of capillary 
plexuses is correlated with the proliferation of the mammary 
epithelium whereas increase in secretory function is associated with 
dilatation of those capillaries already present (124). 
Blood Flow Measurement Techniques 
Many procedures are available for measuring blood flow through 
various organs of the body. Some of these procedures are discussed below 
with particular consideration to their application in measuring rat 
mammary gland blood flow. 
Electromagnetic flow meter 
When an electrical conductor (i.e. blood) moves across lines of 
force of a magnetic field, a potential difference is created in the 
/il V» Th4c + 4 m <4* 3 4 w 4'kQi 
v t t  I  •  t  •  w a v i  w t  a i l  
electrodes which also lie across the path of the conductor. If 
a) the field is uniform, b) the conductor moves in a plane at right 
angles to the magnetic field, and c) the length of the conductor extends 
perpendicular to both the field and direction of motion; the resulting 
potential difference is directly proportional to the field strength, 
the flow of the conductor and the length of the conductor within the 
field. If the field strength and length of the conductor within the 
field are constant, then the voltage developed is a linear function of 
the speed of the conductor (59). Such a technique was used to measure 
manonary gland blood flow in the goat by placing an electromagnetic flow 
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meter on the pudic artery (109). This method is impractical in the 
rat because it would be necessary to isolate a mammary artery and to 
find a sleeve of small enough diameter to attach electrodes to that 
artery once isolated. 
Thermodi1uti on 
The principle of this method is that saline, cooler than blood, 
is injected at a known temperature and constant rate into a vein. A 
thermocouple or thermistor, lying in a blood vessel downstream measures 
the fall in temperature of the blood saline mixture. Knowing the 
temperature of the blood stream, the rate of flow can be calculated. 
Thermodilution is used to measure cardiac output and regional blood 
flow. Fegler (32) measured cardiac output in the goat by injecting 
cold saline into the right jugular vein and placing the thermistor into 
the aortic arch via the left carotid artery. Lir.zsH (75) used this 
method to measure goat marranary gland blood flow by injecting cold 
saline into an exteriorized subcutaneous milk vein, recording the fall 
in blood temperature 10-25 cm downstream. Again, the difficulty in the 
rat is the isolation of an appropriate manmary vein. 
Pick method 
The time taken for an organ to become saturated with a freely 
diffusible substance is proportional to the rate it is delivered to 
the organ. If the amount of substance in the organ and the mean 
arterio-venous difference during uptake are known, then the flow rate 
is calculated by dividing the former by the latter. Several methods are 
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are based on this principle. 
Antipyrine method Reynolds et al. (109) measured goat mammary 
gland blood flow by injecting a know quantity of antipyrine into the 
milk duct system of the udder. They knew the quantity of antipyrine 
by measuring the amount remaining in the milk after 30 minutes. During 
the absorption period, they took blood samples from the carotid artery 
and subcutaneous abdominal vein to determine the arterio-venous 
difference. Knowing the rate of absorption of antipyrine at the time 
of sampling, they calculated the blood flow through the mammary gland. 
Clearance method An estimate of blood flow per unit volume of 
tissue can be made from the rate at which a freely diffusible indicator 
is cleared from the tissue; the faster the flow, the quicker the 
elimination (61). The Pick principle is simplified if xenon or krypton 
is used as the indicator because these are almost completely eliminated 
from the venous blood in one passage through the lung; therefore, it 
is not necessary to measure the arterial concentration (15, 105). This 
procedure was chosen to measure rat maranary gland blood flow and is 
discussed in greater detail beginning on page 38. 
Indicator fractionation 
The principle of the indicator fractionation method is that 
following a rapid injection into the right atrium, an indicator is 
uniformly distributed in the arterial blood and is delivered to the 
tissues in proportion to their blood supply. If the indicator is a 
freely diffusible substance, it passes rapidly from the circulation 
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into the tissue. Provided that it is extracted at an equal rate by 
all tissues, the proportion of the indicator in each tissue, soon after 
injection, represents the organ's share of the cardiac output. Therefore, 
if the circulation is stopped soon after injection and the tissues 
removed quickly, the distribution of the cardiac output is determined 
by measuring the amount of indicator in each organ. If the cardiac 
output is known, the blood flow to any organ can be calculated (50). 
Sapirstein (114) applied this inethod to determine regional blood 
OC 
flow in the rat. He injected radioactive rubidium chloride ( RbCl) into 
the femoral vein. From one group of animals, he removed blood samples 
from the carotid artery to determine the cardiac output. From another 
group he removed various organs and measured the uptake of radioactivity 
by each organ to determine the fractional distribution of the cardiac 
output to each organ. From the cardiac output and percent distribution; 
he computed the blood flow to each organ. 
A difficulty with this method is that if the indicator used remains 
in the circulation after the first transit, as with rubidium, mathematical 
integration of the transit curves after correcting for recirculation is 
required. If, on the other hand, the indicator is retained in the 
tissue during the first transit, the integration is accomplished 
physically, and the need to determine transit time is eliminated. Thus, 
Minnesota Mining and Manufacturing Company developed radioactively 
labelled microspheres that are removed from the blood stream by becoming 
entrapped in the microcirculation of the organ. The limitation in 
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using microspheres to determine regional blood flow is related to 
both the diameter of the vessels and the size of the microspheres. 
Because capillary diameter may vary from organ to organ, the size of 
the microspheres chosen becomes important (88, 142). 
To determine blood flow by measuring the disappearance rate of a 
locally injected indicator, one must assume that there is no difference 
in the solubility of the indicator in blood or in tissues and that 
complete equilibrium is reached almost instantaneously between the tissue 
and its blood. This implies that diffusion is not a limiting factor 
and that blood flow through the tissue partakes in the equilibration, 
i.e., there are no arterio-venous shunts. On the basis of these 
assumptions plus the Pick principle, Kety (62) derived a generally 
applicable expression for inert gas uptake by a single tissue. 
For an inert gas the Pick principle can be stated as follows: 
the amount of inert gas taken up by the tissue per unit time is equal 
to the quantity brought to the tissue by the arterial blood minus the 
quantity carried away in the venous blood: 
Xenon Clearance Method 
Since u = ^ i = tissue 
a = arterial 
v = venous 
(1) Q = amount 
C = concentration 
Where: 
Then dC- , dQ. 
dr4dt V F = flow 
V = volume 
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From the basic assumption that blood from a tissue is in 
equilibrium with the tissue itself, with respect to the inert gas, 
then at all times: 
Ci = XCy (2) 
Where X is the partition coefficient, a correction factor for the 
difference in solubility of an inert gas in different tissues usually 
expressed as: 
conc. of inert gas in tissue 
conc. of inert gas in blood 
By substituting of Equation 2 into Equation 1: 
Which, if C, and therefore XC are constant, then the expression 
a a 
for the desaturation of an inert gas from a tissue is: 
where k,. = or ^i = kX 
X-V. V. 
Where k is the clearance constant, C,- is the final concentration, 
and is the initial concentration. 
In the past, sodium-24 (^^Na) and iodine-131 were used to 
measure blood flow by the clearance method with considerable variability 
or 
in results. The chemically inert gases krypton-85 ( Kr) and xenon-133 
133 ( Xe) have certain advantages over sodium and iodine. They are 
chemically and physiologically inert; they are not normally found in 
the body; they are highly lipid soluble allowing them to pass freely 
through cell mentranes (144); and they are rapidly excreted from the 
body via the lungs (16). The long physical half-life of (10.3 
133 years) and Xe (5.27 days) made the use of these nuclides more 
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convenient than Na (15 hours). Finally, the lower gamma ray energies 
of ^^Kr (0.513 Mev) and ^^^Xe (0.081 Mev) are more suitable for external 
radiation detection than the high energy of ^^Na (1.368 Mev) which is 
difficult to localize accurately in the body. 
133 One important reason for choosing Xe as the indicator in 
measuring blood flow is that it comes out of solution very rapidly 
when exposed to air. This means that the clearance of xenon from the 
mixed venous blood is almost complete in one passage through the lungs 
and that the recirculation of the tracer via the arterial circulation 
is negligible. However, this same property increases the difficulty 
in measuring the partition coefficient of xenon in different tissues 
since the gas is lost to the atmosphere upon exposure of the tissue to 
air. 
In spite of the fact that a great number of studies have involved 
the use of the xenon clearance method to measure blood flow (see Table 1), 
there have been very few reports of methods used to estimate the xenon 
partition coefficient. Some of the data reported is derived fron 
in vitro work. Conn's (20) experiments were performed on dog tissues 
and those of Isbister et al. (57) and Veall and Mallett (139) on 
human whole brain, gray and white matter. 
Andersen and Ladefoged (3) described an in vivo method for 
determining the partition coefficient in the rat and rabbit. They 
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Table 1. Summary of studies using xenon clearance method to measure 
blood flow. 
Tissue Site of 
studied Species Injection References 
Kidney Human Renal artery 68 
Spleen Human Splenic artery 9 
Spleen Guinea pig Spleen 113 
Li ver DOy Hepatic artery/portal vein 108 
Small gut mucosa Dog Lumen 48 
Adipose Human Subcutaneous abdominal 72, 102 
Cerebrum Human Cerebrum 30 
Cerebrum Human Carotid artery 54 
Hypothalamus Rabbi t Hypothalamus i n  
Skeletal muscle Human Anterior tibial 49, 72 
Myometrium Human Myometrium 
00 00 in 
placed animals in an air-tight box containing an air-xenon mixture. 
After 24 hours the animals were exsanguinated and tissue and blood 
samples taken, all manipulations being carried out in the box from 
outside using air-tight gloves. Samples were placed in air-tight 
tubes containing concentrated hydrochloric acid to digest the tissue. 
After another 24 hours, the samples were removed from the chamber, 
counted in a well-scintillation counter and the tissue:blood partition 
coefficient computed. 
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Another in vivo method for measuring the partition coefficient 
is described by Rosendorff and Luff (111). They injected both Xe-133 
and I-125-antipyrine (lAP) into the tissue. The simultaneous clearance 
of these two isomers was measured with an external scintillation 
counter. Because the two isotopes are being cleared by the same blood 
flow, the ratio of clearance rates (T^) is related to the ratio of 
the partition coefficients (X): 
]MM- = itiâL 
\(IAP) ^{lAP) 
The non-volatile (Xj^p) can be easily determined and the calculated. 
Rat Mammary Gland Blood Flow 
Linzell and coworkers (14, 76) seem to be the only people publishing 
rat mamnary gland blood flow data. They estimate blood flow in tissues 
by combining Fegler's (32) thermodilution method of measuring cardiac 
output with Sapirstein's (114) indicator fractionation technique of 
determining cardiac output distribution. A catheter coupled with a 
thermistor is placed into the right atrium via the right jugular vein, 
while a second catheter is attached to the left carotid artery. The 
cardiac output is measured by rapidly injecting saline at room 
temperature into the right atrium and recording the passage of cooled 
blood moving from the heart through the carotid as it passes the 
arterial thermistor. By injecting ®®RbCl through the catheter in the 
jugular vein, quickly killing the animal, removing the organs and 
counting their radioactivity, the percent of the original injected 
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radioactivity and cardiac output distribution is calculated. From 
these parameters, cardiac output and its distribution, Linzell and 
coworkers calculated blood flow in ml/min/lOOg tissue. Their results 
are summarized in Table 2. 
Table 2. Mammary gland blood flow during late pregnancy and lactation 
Pregnancy®''^ Lactation^ Lactation^ Lactation ® 
day 22 day 1 day 2 day 12 
Mammary gland 
Wet wt./B.W. (%) 5.00 + .30 5.25 + .50 4.75 + .15 7, .63 + .28 
% Cardiac output 4.61 + .45 7.25 + .90 8.25 + .30 9 .96 + .74 
Blood flow 33.90 + 3.70 50.00 + 3.30 68.00 + 3.30 61 .70 + 6.00 
(ml/min/lOOg) 
^Chatwin et al. (14). 
^Linzell (76). 
If my values for rat mammary gland blood flow during late pregnancy 
and early lactation agree with Linzell's data, then I can be confident 
that the xenon clearance method is a valid technique for measuring rat 
mammary gland blood flow. 
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METHODS 
Treatment of Animals 
Sprague-Dawley-Rolfsmeyer rats were used in this study. Pregnant 
rats were obtained by placing five adult females and one adult male in 
a large cage for breeding. The presence of sperm in the vaginal smear 
was considered day 1 of pregnancy. Pregnant animals were housed 
individually and were either sacrificed or. day 21 or permitted to 
continue to term and sacrificed on the first, third or fifth day of 
lactation. Litters were standardized to 8 pups per litter. Experimental 
rats were ovariectomized or ovariectomized and hypophysectomized and 
given the appropriate hormonal therapy to simulate late pregnancy or 
early lactation. The recovery time between each operation and the 
initiation of hormonal therapy was six days. 
All animals were provided with Wayne Lab Blox and tap water or 5% 
glucose solution for hypophysectomized rats ad libitum. The temperature 
was controlled at 25°C +3° and the lighting was regulated with light 
hours between 8:00 a.m. and 10:00 p.m. 
Surgical Procedures 
Bilateral ovariectomy was performed using the ventro-lateral 
approach. The rat was anaesthetized with ether, the body wall opened, 
the uterus ligated at the junction of the oviduct, ovaries removed, 
abdominal muscles sutured, and wound clips applied to the skin. 
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Hypophysectomy was performed by the intra-auricular method, using 
the Hoffman-Reiter Hypophysectomizer stereotaxic device. The ear canal 
was swabbed with 70% ethanol. The pinna was snipped above and below 
the ear canal to facilitate positioning of the ear bars. An 18 gauge, 
thin walled, wide beveled needle attached to a 10 ml syringe was inserted 
through the right ear canal and guided to a position above the sella 
turcica. The pituitary war removed by aspiration (147). Upon sacrifice, 
the sella turcica and any overlying tissue was fixed in 10% buffered 
formalin and stored in 70% ethanol for histological examination (55) as 
an indication of effectiveness of hypophysectomy (Appendix I). 
Hormone Preparations 
Estrogen-Progesterone (EP) 
A stock estrogen solution of 1.0 mg of estradiol benzoate per 
1.0 ml of carrier was prepared. The carrier was 5.0% benzyl alcohol 
and 95.0% Mazola Corn Oil. To prepare the estrogen-progesterone 
solution for injection, 1.0 ml of stock estrogen was diluted with 99 ml 
of carrier. Three grams of progesterone was dissolved in this mixture. 
To enhance dissolving, the mixture was continually stirred at 35°C for 
four hours. The quantity injected was 1 ug E + 3 mg P in 0.1 ml corn oil. 
Pituitary hormones : bovine pro1action (PRL) and bovine growth hormone (GH) 
Although these hormones are usually provided in bulk they are 
unstable in saline, therefore it is best to prepare them in small 
quantities, usually 50 mg at a time every three days or as needed. 
46 
Prolactin {NIH-P-B4) and growth hormone (NIH-GH-B17) was dissolved 
in less than 5 ml of .9% saline adjusted to pH of 9.0-9.5 to 
facilitate solubility, then filled to volume (5 ml). The injected concen­
tration was 1 mg PRL or 1 mg GH in 0.1 ml of alkaline saline. 
Hydrocorti sone acetate (£) 
The suspension medium was mixed by adding 1 drop of Tween 80 per 
5 ml of saline adding benzyl alcohol as a preservative; 0.9 ml per 
100 ml of saline. Hydrocortisone was placed in a tissue homogenizer 
with a small portion of the required volume of suspending medium and 
ground several times to ensure complete suspension (about 15-30 minutes). 
The suspension was then poured into a storage bottle. The tissue 
homogenizer was washed several times with the remaining suspending 
medium and the washings added to the storage bottle. The solution was 
shaken before each injection to maintain the suspension. The animal was 
given 250 yg F in 0.1 ml saline. 
Treatment groups and symbols used to identify them are listed in 
Table 3. Subcutaneous injections of the hormones were given daily. 
Mammary Gland Nucleic Acid Analysis 
DNA and RNA analysis was performed on the six abdominal-inguinal 
rat mammary glands. The procedure is described in detail in Appendix II, 
Table 3. Treatment groups 
Group 
symbol 
Surgical 
procedure 
Hormonal 
treatment 
Day of 
sacrifice 
^^20 Ovariectomy lljgE-3mgP (19d.)* 21 
^21 None None 21 
HPS Ovariectomy and 
hypophysectomy 
lygE-3mgP {10d.)+ 
lygE-SmgP + lmgGH-lmgPRL-250ygF (lOd.) 
21 
HPU Ovariectomy and 
sham-hypophysectomy 
lygE-3mgP (10d.)+ 
lygE-3mgP lmgGH-lmgPRL-250ygF (lOd.) 
21 
h None None 23 
^3 None None 25 
(-5 None None 27 
HLS Ovariectomy and 
hypophysectomy 
lygE-3mgP (10d.)+ 
lygE-3mgP + lmgGH-lmgPRL-250ygF (10d.)+ 
lmg6H-lmgPRL-250ygF (3d.) 
24 
^Consecutive days injected. 
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Mammary Gland Blood Flow 
Clearance rate {1^) 
Xenon-133 was purchased from Amersham-Searle Corporation. It 
was dissolved in isotonic saline and contained in a 1 ml air-free 
cartridge syringe, 10 mC/ml. An injection dose of 0.5 mC or 0.05 ml 
was sufficient to detect its elimination from the mammary gland. 
Xenon comes out of solution very rapidly when exposed to air. To prevent 
evaporation of xenon from the syringe between animal injections, the 
needle was forced through a rubber pharmaceutical stopper into a 
holding vial saturated with xenon. To prevent evaporation overnight, 
the needle was dipped into melted beeswax and allowed to cool forming 
a plug in and around the bevel of the needle. The beeswax could be 
removed without dulling the needle by briefly warming the tip in hot 
Water. 
All animals were anaesthetized with Nembutal (40 mg/kg B.W.). 
A mid-ventral and lateral incision was made. The flap of skin was 
pulled aside to expose the left abdominal-inguinal mammary glands. 
The xenon was injected directly into the first left abdominal-inguinal 
mammary gland close to the superficial epigastric artery. A 0.5 inch, 
26 gauge needle was used and inserted at an oblique angle into the 
mammary gland to a depth of about 3 mm. The needle was withdrawn, 
the flap of skin closed with a wound clip, the area of the mammary gland 
was centered under the detector and the recording of the elimination 
rate began within 45 seconds of the initial injection (Fig. 7). 
7. Detection equipment for the measurement of the mammary gland 
xenon clearance rate 
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The elimination rate of the injected xenon was followed by an 
external scintillation detector with a 5 x 5 cm Nal(Tl) crystal. A 
rectangular lead collimator was used with an inner slit of 2 x 4 cm 
and a length of 11 cm from the crystal to the aperture. The rat was 
positioned such that the area of the mammary gland was centered under 
and was a total of 14 cm from the detector. The scintillation detector 
was coupled to a single channel analyzer to record the counting rate 
of the 81 Key gamniaradiation of xenon. The single channel analyzer 
was connected to a programmable printer lister. The clearance rate 
was continually recorded for 25 minutes. A counting interval of 12 
seconds was chosen. A semi logarithmic plot of the counts per 12 
second interval versus time was drawn and the slope (T, ) of the line 
% 
determined. 
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To determine the partition coefficient, I modified the method 
reported by Andersen and Ladefoged (3). Five animals were housed 
individually in an air-tight environmental chamber containing atmospheric 
air and between 5-10 mC of xenon purchased from New England Nuclear 
(Fig. 8). All animals were provided with Wayne Lab Blox and tap water 
or 5% glucose solution for hypophysectomized rats ad libitum. The 
temperature in the chamber was 27°C and continuous lighting was 
maintained. For safety purposes, a negative pressure was maintained 
within the chamber at all times. Because the rats remained in the 
chamber for 24 hours to equilibrate with the xenon, the surplus carbon 
Fig. 8. Air-tight chamber for the measurement of the mammary gland: 
blood partition coefficient for xenon 
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dioxide was absorbed by soda Time and water vapor with drierite. In 
order to both maintain a negative pressure and keep the animals alive 
within the chamber, the flow rate of oxygen (95% Og, 5% COg) supplied 
was approximated from rat metabolic rates reported by Brody (11): 
Approximate oxygen 
consumption rate 
(ml/min) 
Virgin 3.8 
Pregnant 5.3 
Lactating 4.5 
Pup 0.5 
Hypophysectomized 3.5 
To avoid loss of xenon from the samples to the air during mani­
pulations, all procedures were carried out in the chamber from outside 
with the aid of air-tight gloves. To permit these manipulations, the 
pressure in the chamber was increased slightly with an external 
carbon dioxide source. 
After living in the chamber for 24 hours, the animals were 
anaesthetized with Nembutal. Blood and liver samples weighing 2.0-3.0 g 
and mammary gland samples weighing 1.0-2.0 g were taken and placed in 
tared 0.5 dram glass vials. The vials were topped with xenon-equilibrated 
water to remove all air bubbles from the vials and tightly sealed with 
teflon coated caps to prevent evaporation. Glass instead of plastic 
vials were used to minimize the residual xenon contamination (127). A 
small sample of blood was withdrawn into heparinized capillary tubes 
to determine the hematocrit. 
After a 24 hour period, the chamber was vented into a radioactive 
hood, the vials were removed and finally the radioactivity was measured 
in a well-scintillation counter with a 10 x 10 cm Nal(Tl) crystal and 
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well dimensions 1.9 cm in diameter and 6.5 cm deep. The detector was 
coupled to a single channel analyzer in coincidence with a 400 channel 
multichannel analyzer so everything falling within the window could be 
visually monitored. To determine the actual counts contributed by the 
tissue, the activity due to the water and the residual glass contami­
nation in the vial were subtracted from the total counts. At least 
10,000 net tissue counts were recorded. 
The partition coefficient was obtained from ccuRts/min/g tissue 
divided by counts/min/g blood, the sample values being the mean value 
of all that tissue type taken from an individual rat. The partition 
coefficients (g/g) were calculated from 50% hematocrit (3) according to: 
AHct.. = XHctrn Hct^ + 1.02 
^ 1758 
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The blood flow was calculated from the clearance constant (k) and 
the hematocrit corrected partition coefficient (62) according to: 
(ml/miS/g tissue) " "^*^6 k = 
2 
Statistics 
The effect of each treatment on mammary gland DNA, RNA and blood 
flow was tested for statistical significance by Student's t test using 
a pooled variance. 
54 
RESULTS 
For the purpose of clarity in reporting the results, the data are 
presented in the following sections: 
1. Body weights and mammary gland weights 
2. Mammary gland DNA 
3. Mammary gland RNA 
4. Mammary gland blood flow 
The statistical comparisons reported for each parameter of mammary 
gland development are as follows: 
1. Ovariectomized, estrogen-progesterone treated (ERgg) animals 
and ovariectomized, sham-hypophysectomized simulated pregnant (HPU) 
animals versus normal pregnant (Pg^) controls, i.e., 
EPpn and HPU versus P,, 
2. Ovariectomized, hypophysectomized simulated pregnant (HPS) 
and lactating (HLS) animals versus normal pregnant (Pg^) and lactating 
(L-j) controls, i .e., 
HPS and HLS versus P^i and L^ 
I I 
3. HPU versus HPS 
4. HLS and L^ versus HPS and Pg^ 
After histological examination of the sella turcica to verify the 
completeness of hypophysectony, a comparison was made between animals 
with microscopic amounts of pituitary present (HL?) and those with no 
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pituitary present (HLS) with respect to body weights and mammary gland 
dried fat-free tissue weights (Table 4), DNA parameters (Table 5) and 
RNA parameters (Table 6). There was no significant difference between 
these two groups in any parameter compared, therefore, the data from 
these two groups were combined into one group and designated as 
successfully hypophysectomized (HLS) animals. 
Table 4. Effect of hormonal treatment on body weight and mammary gland 
DFFT in complete and partially hypophysectomized rats 
B. W.b(g) DFFT^(mg) 
Group n® (mean) (mean) 
HLS 7 212 450 
HL? 9 224 576 
^Number of animals per group. 
^Body weight. 
''Dried fat-free tissue weight. 
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Table 5. Effect of hormonal treatment on mairenary gland DNA in 
complete and partially hypophysectomized rats 
yg DNA Total mq DNA 
Group n 
mg DFFT 
(mean+s.e. ) 
mg DNA 
(mean+s.e.) 
lOOg B.W. 
(mean+s.e.) 
HLS 7 19.45 + .37 8.80 +1.16 4.10 + .38 
HL? 9 18.48 + .70 10.48 + 0.79 4.66 + .29 
"Standard error. 
Table 6. Effect of hormonal treatment on mammary gland RNA in 
complete and partially hypophysectomized rats 
nàtA 
mg RNA lOOg B.W. DNA 
Group n (mean+s.e.) (mean-fs.e.) (mean+s.e.) 
HLS 7 19.96+3.92 9.20+1.52 2.18 + .21 
HL? 9 27.60+3.40 12.22 + 1.32 2.56 + .13 
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Body Weight and Mammary Gland Weight 
Final body weight (Table 7) 
Final body weights of EPgg (256 g) and HPU (259 g) animals were 
similar to those of normal pregnant controls (252 g). Body weights 
of HPS (228 g) and HLS (219 g) were less (P<.05, P<.001, respectively) 
than those of normal pregnant and lactating controls (252 g, 255 g, 
respectively). The HPU and HPS animals were given the same hormonal 
treatment but the average body weight of the latter group (228 g) was 
significantly less (P<.01) than the former (259 g). There was no 
significant difference observed in body weight of HLS (219 g) and 
L-j (256 g) animals when compared with their pregnant equivalence, 
HPS and Pg^, (228 g, 252 g, respectively). 
Mammary gland dried fat-free tissue weight (Table 7) 
No significant difference was observed between the mammary gland 
.dried fat-free tissue weights (DFFT) of EPgg (578 mg) animals and 
their pregnant controls (676 mg). But, the DFFT of HPU (813 mg) was 
much greater (P<.001) than that of the same controls. DFFT weights 
of HPS (348 mg) gnd HLS (521 mg) animals were significantly less 
(P<.001) than those of their corresponding pregnant and lactating 
controls (676 mg, 875 mg, respectively). The mammary glands of the 
HPU (813 mg) animals responded to the hormonal replacement to a much 
greater extent (P<.001) than the HPS (348 mg) animals. DFFT weights 
of HLS (521 mg) and L^ (875 mg) lactators were greater (P<.01) than 
those of their pregnant counterparts, HPS and Pg^, (348 mg, 676 mg, 
respectively). 
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Table 7. Effect of treatments on body weight and mammary gland DFFT 
Group n 
B.W.(g) 
(mean) 
DFFT(mg) 
(mean) 
m
 
o
 10 256 578 
2. P21 10 252 676 
3. HPS 12 
+2-3 
228^ 
*2-3 
348 
4. HPU 6 259g>4 813*3_ 
5. 12 256 
un 
LO CO 
6. Lg 13 276 871 
7' 4 12 272 1006 
8. HLS 16 
*5-8 
219 
*5-8 
521 g 3-8 
t denotes significance at the .05 level. 
§ denotes significance at the .01 level. 
* denotes significance at the .001 level. 
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Mammary Gland DNA 
DNA per mg DFFT, total mq DNA, and mg DNA per 100 £ body weight (Table 8, 
Figs. 9, 10, 11) 
No significant differences were observed for any of the DNA 
parameters between EPgg and HPU animals and their normal pregnant 
controls. The number of cells per unit area (yg DNA/mg DFFT) and total 
number of cells (total DNA) of the HPS and HLS animals were significantly 
less (P<.01) than their corresponding normal pregnant and lactating 
controls. The mammary glands of the HPU animals were more sensitive to 
the hormonal therapy (P<.025) than the HPS animals for all the DNA 
parameters. Although a significantly smaller (P<.001) ug DNA/mg DFFT 
was demonstrated for HLS and L-j animals when compared with their 
pregnant counterparts, HPS and Pg^, there was no significant difference 
between comparisons of these same groups in relation to total DNA and 
mg DNA/100 g B. W. 
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Table 8. Effect of treatments on mammary gland DNA 
yg DNA Total mp DNA 
mg DFFT mg DNA lOOg B.W. 
Group n (mean+s.e.) (mean+s.e.) (mean+s.e.) 
1. o
 
LU 
10 32.97 + 1.28 18.65 + 1.05 7.27 + .28 
2. 
^21 10 29.97 + 0.99 19.96 + 1.23 7.99 + .49 
3. HPS 12 23.54 + o
 
u
n
 
*2-3 
8.20 + 0.57 3.60 ^ .24*^ ^ 
4. HPU 6 28.10 + 1 .48^3-4 22.59 + 0.99*3-4 8.72 + • 28*3-1» 
5. h 12 22.20 + 
*2-5 
0.62 19.26 + 0.68 7.54 + .24 
6. 
"-3 13 25.54 + 0.81 22.18 + 0.86 8.04 + .30 
7. 12 24.52 + 0.44 24.57 + 0.94 9.06 + .31 
8. HLS 15 18.90 ^ 
*5-8 
r\  ^o 
u.to^3-e 
* 5-8 
9.75 + 0.68 4.42 + • 3-9 
t denotes significance at the .05 level. 
§ denotes significance at the .01 level. 
* denotes significance at the .001 level. 
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Maranary Gland RNA 
Total mg RNA, mg RNA per 100 £ body weight, and RNA/DNA ratio (Table 9, 
Figs. 12, 13, 14) 
The matrenary gland RNA parameters of the EPgQ animals were not 
significantly different from their normal pregnant controls. However, 
these same parameters were significantly higher (P<.025) in HPU animals 
when compared to the same controls. Significantly lower values (P<.001) 
were observed for the RNA parameters of the HPS and HLS aniînals when com­
pared with their respective normal pregnant and lactating controls. In 
comparing the RNA of HPU with HPS animals, the mammary glands of the 
former group were much more responsive (P<.001) to the hormonal 
replacement than the latter group. The RNA parameters of HLS and 
animals were universally greater (P<.001) than their pregnant equivalence, 
HPS and P^y 
Mammary Gland Blood Flow 
A representative clearance curve for each group considered in this 
study, plotted in a semi logarithmic diagram, is seen in Fig. 15. In 
order to include all groups on the same plot, sr. arbitrary log seals 
is used. To be certain that these clearance curves represent blood 
flow carrying xenon away from the mammary gland, an animal was sacrificed 
prior to injection and the disappearance of the xenon was followed. The 
xenon remained within the mammary gland indicating that I was measuring 
a component of blood flow. A closer look at one of these curves 
(Fig. 16) reveals that it can be analyzed into two components, a fast 
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Table 9. Effect of treatments on mammary gland RNA 
Total mg RNA RNA 
Group n 
mg RNA 
(mean+s.e.) 
lOOg B.W. 
(mean+s.e.) 
DNA 
(mean+s.e.) 
1. m
 
o
 10 30.23 + 3.10 11.66 + 1.02 1.59 + .11 
2. 
^21 10 36.74 + 2.86 14.65 + 1.02 1.84 + .06 
3. HPS 12 
*2-3 
11.45 + 0.92 5.06 
*2-3 
+ 0.44 
*2-3 
1.39 + .05 
4. HPU 6 50.07 + 4.25*^1 19.17 
+2-; 
+ i.ul^ 
s 2-4 
2.19 + .11*3-4 
5. 
•"l 12 
*2-5 
59.26 + 3.45 23.06 
*2-5 
+ 1.02 
*2-5 
3.06 + .10 
6. 
^3 13 63.36 + 4.89 23.03 + 1.83 2.84 + .17 
7. 
^5 12 86.12 + 4.34 31.94 + 1.82 3.51 + .14 
8. HLS 16 
*5-8 
24.26 + 2.67*3-8 10.90 
*5-8 
1 ."4*3-6 
*5-8 
O 00 J- 19 
• .14.* 3-e 
t denotes significance at the .05 level. 
§ denotes significance at the .01 level. 
* denotes significance at the .001 level. 
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(1.5 min) and a slow (16.60 min) component. The fast component 
represents the diffusion of xenon from the injection site into the 
tissue and the slow component represents a factor of blood flow, the 
clearance rate. 
Clearance rate, partition coefficient, and blood flow (Table 10, Figs. 17, 
18, 19) 
Although there was no significant difference observed for the 
clearance rate, the partition coefficient and blood flow were 
significantly lower (P<.01) for EPgg animals when compared with normal 
pregnant controls. The clearance rate and blood flow of HPU animals 
were similar to those of normal pregnant controls. A significantly 
slower clearance rate and a correspondingly slower blood flow (P<.001) 
were observed for HPS and HLS animals when compared with their nornal 
pregnant and lactating controls. Again, the clearance rate and blood 
flow data indicate that the HPU animals are more sensitive (P<.001) to 
the hormonal replacement than the HPS animals. Although there was no 
significant difference observed between the HLS and HPS animals with 
respect to clearance rate and blood flow, there was a much faster 
(P<.001) clearance rate and blood flow for the normal lactating animals 
when compared with the normal pregnant animals. 
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Table 10. Effect of treatments on mammary gland blood flow 
Tj, in 
min X 
Group (mean+s.e.) (mean+s.e.) B.F. ml/min/g 
1. m
 
o
 17.06 + 0.78(21) 6.10 + .44(4) .248 + .011 
2. 
^^21 15.58 +1.40(10) 
, *1-2 
8.30 + .48(6) .369 +_ §1-2 .033* 
3. HPS 32.72 + 3.27(12)** ' 8.51 + .37(7) .180 + 
*2-3 
.018 
4. HPU 13.42 i 1.56(6) *3-4 d.51 .37(7) .439 + .051*3-4 
5. h 
*2-5 
7.68 + 0.85(12) 7.50 + .32(4) .677 + 
*2-5 
.075 
6. 
"-3 6.59 + 0.95(12) 5.14 + .39(7) .540 + .078 
7. 
^5 7.68 + 0.80(12) 4.61 + .17(6) .416 + .043 
8. HLS 29.23 + 2.94(16)*^ ^ 8.34 + .34(10) .198 + 
*5-8 
.023 
(#) number animals per group 
t denotes significance at the .05 level. 
§ denotes significance at the .01 level. 
* denotes significance at the .001 level. 
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DISCUSSION 
It has been suggested that a complex of hormones consisting of 
estrogen, progesterone, growth hormone, prolactin and hydrocortisone, 
stimulates lobulo-alveolar proliferation in ovariectomized, hypo-
physectomized rats comparable to that found in late pregnancy. Further­
more, by removing estrogen and progesterone stimulation but continuing 
treament with growth hormone, prolactin and hydrocortisone, lactation 
is induced (15, 19, 81). I repeated these experiments using quantitative 
indices of mamnary gland growth, i.e., DNA-RNA analysis and blood flow 
measurements rather than the qualitative measure of histological 
examination of whole mount tissue. 
The optimum concentration of each hormone used in this study was 
chosen from several previous studies reported in the literature: 
1 . Ip^E 3myP (54) 
2. l-2mgGH + l-2mgMH (46) 
3. 250ygF (4) 
Although it has been suggested that 2%g:6mg is a better combination 
of estrogen and progesterone for synergism with other hormones than 
lyg:3mg (46, 94), I wanted to duplicate the work of Chen et al. (15) 
and Cole and Hopkins (19), who used lyg:4mg, and Lyons et al. (81), who 
used lyg:2mg; therefore the combination of lygiSmg was chosen for this 
study. 
An important result of this research is that total hypophysectomy 
is not necessary. A microscopic fragment of pituitary tissue may remain 
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and the animal still responds as if completely hypophysectomized. 
However, if visual amounts of pituitary tissue remain, the animals 
respond as if sham-operated. 
Mammary Gland DNA and RNA 
Since no significant difference was observed, with reference to 
any of the DNA or RNA parameters, between ovariectomized, estrogen-
progesterone (EPgg) treated animals and their pregnant controls, Î 
concluded that the estrogen-progesterone treatment was optimum for 
mammary gland proliferation comparable to late pregnancy. However, 
this same degree of growth was not stimulated with the five hormone 
complex administered to ovariectomized, hypophysectomized rats, 
although some development of the manmary gland was achieved. The DNA 
values of the equivalent sham-hypophysectomized animals did demonstrate 
successful stimulation of manmary gland growth similar to late 
pregnancy, while the synthetic capability of the manmary gland was even 
greater than the controls. Therefore, I concluded that the pituitary 
replacement therapy was not adequate for mammary gland growth equivalent 
to late pregnancy. From a similar comparison, with respect to DNA and 
RNA data, between simulated lactating (HLS) animals and their normal 
lactating controls, the same conclusion can be drawn: that the 
pituitary replacement therapy was inadequate for mammary gland 
proliferation similar to early lactation. It was demonstrated, however, 
that the DNA and RNA values of the simulated lactating (HLS) animals 
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when compared with the simulated pregnant (HPS) rats paralleled a 
similar comparison between the normal lactating and pregnant animals, 
as indicated below. 
yq DNA 
DFFT 
Total 
DNA 
Total 
RNA ill
 
1=2, VS L^ 26%+ N.S. 38%+ 40%+ 
HPS vs HLS 22%+ N.S. 53%+ 42%+ 
where a decrease in yg DNA/DFFT indicates an 
increase in cell size and total DNA represents 
cell number 
The DNA and absolute values of the simulated (HPS, HLS) animals were 
less than their normal controls (Pg^, L-j). However, the percent 
increase in cell size and synthetic capability of the normal lactating 
animals over the normal pregnant animals was the same as the percent 
increase in DNA and RNA of the simulated lactating animals over the 
simulated pregnant animals. Therefore, the cessation of estrcgar: ar.d 
progesterone administration did imitate the events occurring during 
parturition. 
Because mammary growth was stimulated to some degree in HPS 
rats when compared with virgin animals (110) and the HLS animals did 
secrete milk, it is possible that qualitatively, by histological 
examination, there is no difference between the simulated and normal 
animals although quantitatively there is a definite difference. 
One criticism that might explain the disagreement between the 
quantitative and qualitative results might be that Chen, Lyons and 
Cole all used Long Evans rats while I used Sprague-Dawley animals. 
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However, mammary gland DNA and RNA studies in different rat strains 
(51, 92, 120, 132) have demonstrated no difference between strains. 
Suspecting that the five hormone complex might not be adequate to 
stimulate mammary gland proliferation equivalent to late pregnancy, 
blood flow was measured to determine if it could be a limiting factor 
in mammary gland development. 
Blood Flow 
Of all the methods available for measuring rat mammary gland 
blood flow, the least complicated appeared to be the clearance method 
proposed by Kety (62). This technique permitted the injection of 
a tracer, i.e., Xenon-133, directly into the marranary gland thus avoiding 
the difficulty of isolating a single mammary gland blood vessel. 
To determine blood flow by measuring the disappearance rate (T, ) 
of a locally injected indicator, two assumptions must be met. The 
first assumption, that there is no difference in the solubility of the 
indicator in blood and in tissue, is met by the determination of a 
correction factor, the partition coefficient (X). The second 
assumption-, that there are no arterio-yenous shunts through the tissue» 
is dismissed by Linzell's (77) description of the mammary gland 
capillary network. With these assumptions fulfilled: 
Blood flow = 4^ X = kX 
% 
where there is no recirculation of the indicator 
through the tissue as is the case with Xenon-133 
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Although the clearance rates were not difficult to measure, there 
was tremendous variability in the results. Even so, the same trends 
were noticed when comparing treatments with respect to clearance rates 
as were apparent with the DNA and RNA data. The clearance rate of the 
ovariectomized, estrogen-progesterone treated (EPgg) animals was 
similar to late pregnancy indicating that the estrogen-progesterone 
treatment was a sufficient substitute for the ovaries. The clearance 
rates of the simulated pregnant and lactating (HPS, HLS) animals were 
slower than their normal pregnant and lactating controls while the sham-
hypophysectomized simulated pregnant (HPU) group returned to the 
control levels lending further support to the view that the pituitary 
hormonal replacement was insufficient. 
The partition coefficient was not as easily obtained as the 
clearance rate. Conn (20) and Andersen and Ladefoged (3) independently 
measured the partition coefficient for xenon in different tissues of 
the dog, rabbit and rat but not in the rat mammary gland. For most 
tissues, they found a partition coefficient of 0.7 and this figure is 
used by most investigators measuring blood flow by the xenon clearance 
method. However, adipose tissue had a value of 10.0 indicating a much 
higher solubility of xenon in lipid. This complicated matters because 
as the mammary gland develops, it absorbs the surrounding fat pad. 
This means that there is a continual change in the fat content of the 
maimary gland throughout its development. Therefore, whenever the 
clearance rate is determined the partition coefficient must be measured 
in order to calculate the blood flow for that stage of development. 
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Because I substantially modified Andersen and Ladefoged's (3) 
procedure for determining the partition coefficient, I measured the 
xenon solubility in the liver as well as in the mammary gland to verify 
my technique. My value for the liver partition coefficient was 0.9. 
It has been demonstrated that there is an inverse linear relationship 
between xenon solubility and temperature (69). Andersen and Ladefoged 
(3) measured partition coefficients at 37°C while my measurements were 
made at 27°C. After making the appropriate correction for temperature 
difference, our liver partition coefficients were in agreement. There­
fore, I am confident that the mammary gland partition coefficients for 
the different stages of growth are at least a good first approximation, 
but the number of samples was small and the variability was great. 
After calculating the blood flow from the clearance rates and 
partition coefficients, it was again apparent that there was a 
deficiency in the hormonal replacement of the anterior pituitary. The 
blood flow in the simulated pregnant and lactating (HPS, HLS) groups 
were substantially slower than in their corresponding normal pregnant 
and lactating controls, whereas, the blood flow of the sham-hypo-
physectomized simulated pregnant (HPU) animals was not significantly 
different from the pregnant controls. Although there was a significant 
difference in blood flow between the ovariectomized, estrogen-pro­
gesterone treated (ERgg) animals when compared with the normal pregnant 
rats, this may be because of a possible underestimation of the partition 
coefficient due to the small number of determinations and large 
variability in the data. 
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An examination of the data revealed a dramatic increase in blood 
flow from late pregnancy to early lactation. This agrees with similar 
data reported by Chatwin et al. (14) and Linzell (76) (see Table 2). 
Although we used very different methods in measuring mammary gland 
blood flow, our values do agree and this lends support to the validity 
of the results from the simulated animals. 
An unexpected result of this research was the decrease in blood 
flow noted from day 1 through day 5 of lactation. Since there was no 
difference in manmary gland DNA or RNA from day 1 to day 3 and only an 
increase in the synthetic capability of the mammary gland from day 3 
to day 5 but not in proliferation, I would have expected no change in 
the blood flow. The clearance rates of these animals were constant 
but the partition coefficients decreased. As a result, the blood 
flow also decreased. It is probable that the partition coefficients 
are a good first estimation but further measurements might reveal that 
there is no difference in these partition coefficients and therefore 
no actual difference in blood flow from day 1 through day 5 of lactation. 
The results of this study demonstrate that the estrogen-progesterone 
replacement of the ovary is satisfactory but the prevalent hormonal 
replacement of the anterior pituitary, i.e., growth hormone, prolactin 
and hydrocortisone, is by no means adequate to stimulate mammary gland 
development equivalent to late pregnancy or early lactation. Something 
is missing in this therapy that does not imitate a relationship that 
must exist between the anterior pituitary, blood flow and mammary gland 
proliferation. Various possibilities are mentioned below. 
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1. Blood flow may be a limiting factor in mammary gland develop­
ment. Because the concentration of the hormones injected daily was 
greater than the daily secretion of these hormones from the anterior 
pituitary, it is possible that an inadequate blood supply could prevent 
these hormones from reaching the mammary gland thereby retarding 
growth. An experiment contemplated for the future is to cause either 
general vasodilation, by injection of a drug such as hydralazine, or 
local vasodilation, by application of a heat source directly over the 
mammary gland, in ovariectomized, hypophysectomized simulated pregnant 
and lactating rats to see if we can increase the DNA and RNA content 
of the mammary glands to that of a normal late pregnant animal. This 
might demonstrate the limiting nature of blood flow. 
2. Autoregulation may be involved. As the mammary gland pro­
liferates and its metabolic activity increases, more carbon dioxide 
is produced causing local vasodilation. This would allow more nutrients 
and hormones to reach the mammary gland causing further growth. 
3. Hormones may cause mammary parenchymal growth and coinci-
dentally proliferation of the capillary network, since the parenchymal 
tissue is essential for capillary expansion. The hormones would then 
indirectly cause an increase in blood supply to the mammary gland and 
a feedback system would be activated. 
4. Although the concentration of hormones injected daily may be 
greater than the daily secretion of these hormones from the anterior 
pituitary, when one considers the half-life of these hormones in the 
84 
circulation; growth hormone and prolactin being 20-30 minutes (25) 
and hydrocortisone is 60-90 minutes (39), it is possible that they 
may be removed from the system before they have their full stimulatory 
effect. Also, the vehicle used for administration of these hormones 
is saline. Saline, unlike corn oil the carrier for estrogen-progesterone, 
does not delay the absorption of hormones, therefore a constant level 
of these hormones in the circulation cannot be maintained. The timing 
of the hormone injections may also be important. Because prolactin 
has a semicircadian release with peaks at the end of the light and 
dark periods, it may be necessary to administer prolactin in the evening 
as well as in the morning. 
5. Lastly, the number of hormone receptors in the mammary gland 
may be inadequate therefore, the mammary gland cannot respond to the 
hormonal therapy. 
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SUMMARY 
The present investigation was concerned with the induction of 
mammary gland proliferation equivalent to late pregnancy and early 
lactation in ovariectomized and ovariectomized, hypophysectomized 
Sprague-Dawley rats. To simulate mammary gland development of late 
pregnancy, ovariectomized rats were given daily subcutaneous 
injections of estrogen and progesterone for 20 days. The ovariectomized, 
hypophysectomized animals were injected with estrogen and progesterone 
for 10 days followed by estrogen, progesterone, growth hormone, 
prolactin and hydrocortisone for an additional 10 days to simulate a 
normal late pregnant mamary gland. Estrogen-progesterone stimulation 
was withdrawn while growth hormone, prolactin and hydrocortisone treat­
ment continued for 3 more days to induce milk secretion. 
The nucleic acid content of the six abdominal-inguinal mammary 
glands was estimated colorimetrically while blood flow through these 
glands was determined by the xenon clearance method. Both of these 
quantitative indices were used to assess the extent of mammary gland 
development. 
The results reported here indicate the following: 
1. Estradiol benzoate (1 yg) and progesterone (3 mg) replacement 
of the ovary is adequate to stimulate mammary gland development 
equivalent to late pregnancy. 
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2. Anterior pituitary hormones synergize with estrogen and 
progesterone to induce mammary gland development but the prevalent 
hormonal replacement of the anterior pituitary, growth hormone (1 mg), 
prolactin (1 mg), and hydrocortisone (250 ug), is not satisfactory in 
stimulating mammary gland growth of late pregnancy or early lactation. 
3. Estrogen-progesterone withdrawal imitates the events that 
occur during parturition: an increase in synthetic capability of the 
mammary gland and initiation of lactation. 
4. Blood flow may be a limiting factor in mammary gland develop­
ment. It is possible that mammary gland proliferation and blood flow 
must increase simultaneously to permit further differentiation of the 
mammary gland: 
An important achievement presented in this manuscript is a much 
improved method for determining the mammary gland partition coefficient 
thus permitting the use of the xenon clearance method for measuring 
rat mammary gland blood flow. 
proliferation of the 
mammary gland 
stimulatory hormones 
reach the mammary 
gland 
increase blood flow 
through the mammary 
gland 
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APPENDIX I 
Histological Verification of Hypophysectomy 
Dehydration 
Each tissue was carried through a tertiary butyl alcohol (TBA) 
dehydration series. The tissue remained in each of the following 
solutions for one hour: 
Water Ethanol TBA 
Solution (ml) (ml) (ml) 
1 200 150(95%) 50 
2 120 200(95%) 80 
3 100 200(95%) 100 
4 - 200(95%) 200 
5 - 140(95%) 200 
6 - - Pure 
Infiltration and embedding 
After dehydration; the tissue is ready for infiltration with 
paraplast, a mixture of paraffin and plastic polymers of regulated 
molecular weight. Each tissue was transferred through a series of 
paraplast solutions kept in a warming oven at 60°C. The tissue stayed 
in each solution for one hour. 
Solution TBA Paraplast 
1 75% 25% 
2 50% 50% 
3 - Pure 
4 - Pure 
Following infiltration, the tissue was placed into a small mold 
containing fresh paraplast and allowed to cool. The embedded tissue 
was sectioned at 10 microns and placed on slides. 
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Solutions needed for staining 
1. Aqueous periodic acid: 0.6 g periodic acid and 0.3 ml concen­
trated nitric acid is dissolved in 100 ml distilled water. 
2. Schiff's leuco-fuchsin: 0.5-1.0 g basic fuchsin is dissolved 
in 85.0 ml distilled water. On the day of use, 1.9 g of sodium meta-
bisulfite and 15.0 ml of IN hydrochloric acid are added to the basic 
fuchsin solution. This is filtered through 200 g activated charcoal 
until the stain is water-white. 
3. Iron alum: 5.0 g ferric ammonium sulfate is added to 100 ml 
of distilled water and is stored in a refrigerator. 
4. Harris' hematoxylin: 1.0 g hematoxylin is dissolved in 10 ml 
ethyl alcohol. Dissolve 20 g potassium or ammonium alum in 200 ml 
water and bring to a boil. Add the former to the latter and boil for 
% minute. Add 0.5 g mercuric oxide and cool rapidty. Add a few drops 
of glacial acetic acid to keep away metalic luster. 
5. Orange G: 2.0 g Orange G and 5.0 g phosphotungstic acid are 
dissolved in 100 ml distilled water. Mildly agitate overnight. 
Centrifuge and decant off the clear supernatant. 
Staining procedure 
The length of time the slides remain in each staining solution is 
only an approximation and depends on the final concentration of each 
stain. A trial run must be carried out each day to verify the timing. 
1. Put slides in xylene, two changes, two minutes in each or until 
all the paraplast is removed. 
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2. Put through a descending alcohol series: 95%, 85%, 70%, 50%, 
and distilled water, about one minute in each solution. 
3. Periodic acid...5 minutes. 
4. Wash in running tap water...5 minutes. 
5. Schiff's reagent...10 minutes. 
6. Wash in running tap water...5 minutes and rinse in distilled 
water. 
7. Iron alum...30 seconds. 
8. Wash 3 times in distilled water. 
9. Hematoxylin...dip once, rinse 5 times in distilled water. Check 
the slide and repeat if darker staining is necessary. 
10. Orange G...15 seconds, wash in running tap water for 3 minutes. 
Check the slide and if further destaining is necessary keep in water 
for an additional few minutes. 
11. Put through an ascending alcohol series: 70%, 85%, 95%, 100%, 
100%...dip four times in each or until all water is removed from the 
surface of the slide. 
12. Clear in xylene, 3 changes, and mount in clearmount. 
Check the slides periodically under a microscope for staining 
intensity but be sure they do not dry completely. The stained 
elements should look brilliant because clearmount fades the color. 
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APPENDIX II 
Mammary Gland Nucleic Acid Analysis 
Preparation of dried fat-free tissue (DFFT) 
Immediately after removal, the six abdominal-inguinal mammary 
glands are defatted in approximately 50 ml of chloroformrmethanol 
(2:1 by volume) for two, twelve hour periods. The jars are kept under 
constant mild agitation. The fat-free mammary glands are then dehydrated 
in 50 ml of anhydrous ether for two additional twelve hour periods. 
After the final solvent is decanted, the tissues are air dried. After 
the DFFT is weighed, it is ground to a fine powder using a Wiley mill 
equipped with a number 20 sieve. 
Nucleic acid extraction 
The method used for nucleic acid extraction vias that described by 
Schneider (116) and modified by Ferreri (33). 
1. Twenty five mg of DFFT suspended in 5 ml of 5% trichloroacetic 
acid (TCA) in thick walled 15 ml centrifuge tubes is allowed to stand 
at room temperature until the DFFT becomes saturated (about two hours) 
and settles to the bottom of the tube with gentle tapping. 
2. Samples are covered with glass marbles to prevent evaporation 
and placed in a hot water bath (90-95°C) for 15 minutes and then 
cooled in ice water. 
3. Samples are centrifuged for 15 minutes and the supernatant is 
decanted into 12 ml volumetric centrifuge tubes. 
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4. A second extraction in 5 ml of hot TCA is made on the residue 
and the supernatant is combined with the decant from the first 
extraction. 
5. The total volume is brought up to 10 ml by addition of cold 
5% TCA, transferred to screw capped glass tubes and stored at 4°C. 
Colonmetric determination of DNA content 
The method used was that described by Burton (12) and modified by 
Ferreri (33). 
1. Diphenyl ami ne reagent is prepared on the day it is used. It 
consists of 1.5 g of reagent grade diphenylamine in 100 ml of A. R. 
glacial acetic acid and 1.5 ml of concentrated sulfuric acid. Just 
before use, 0.5 ml of aqueous acetaldehyde (15 mg/ml) is added to the 
reagent. 
2. A stock solution of IN perchloric acid v/as or. hand: 9 nil cf 
concentrated (70%) perchloric acid to 91 ml of distilled water. 
3. One ml of nucleic acid extract or DNA standard is combined with 
4 ml of diphenylamine reagent and 1 ml of IN perchloric acid. 
4. Three blanks are prepared each containing 1 ml of S% TCA, 
4 ml of diphenylamine reagent, and 1 ml of IN perchloric acid. 
5. Color is developed after 16-20 hours of incubation at room 
temperature in the dark, and absorbance is measured against the blank 
at 600 my. 
6. The concentration of DNA in the sample is calculated from the 
least squares estimate of the slope and Y intercept of the standard 
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curve, plotting absorbance vs. concentration. 
Colorimetric determination of RNA 
The method used was that described by Mejbaum and outlined by 
Schneider (117). 
1. A stock solution of 0.5 g of FeCl^per 100 ml of concentrated 
HCl is prepared. Immediately before use, 1 g of orcinol is added 
per 100 ml of this solution. 
2. Five-tenths ml of nucleic acid or 0.5 ml of DNA or RNA 
standard is added to 2.0 ml of 5% TCA. To each tube, 2.5 ml of 
orcinol reagent is added. 
3. Three blanks are prepared each containing 2.5 ml of 5% TCA and 
2.5 ml of orcinol reagent. 
4. The marble covered tubes are incubated in a hot water bath 
(95°C) for 20 minutes to dsvalcp the color, then plunged into ice water-
to halt the reaction. Absorbance is measured against the blank at 
660 my. 
5. Standard curves (absorbance vs. concentration) and least 
squares estimations of the slopes and Y intercepts for both the RNA 
and DNA standards are made. Corrections for absorbance due to DNA 
are made for each sample using the concentrations of the samples as 
previously determined by the Burton procedure. 
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